Trade RNXT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
RenovoRx, Inc. (RNXT) is trading at US$1.67, down 1.18% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$59.57M. Over the past 52 weeks, RNXT has traded between US$0.70 and US$2.59. On Syfe you can trade RNXT with $0 commission and add it to your watchlist.
| Previous close | US$1.69 |
|---|---|
| Market cap | US$59.57M |
| 52-week range | US$0.70 – US$2.59 |
| Volume | 476.73K |
| Exchange | US |
Add to Watchlist
Set Price Alert
RenovoRx, Inc.
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in 2009 and is headquartered in Mountain View, CA.
Year: 2021
RenovoRx, Inc. (RNXT) stock is trading at US$1.67, -1.18% from the previous close of US$1.69.
The market cap for RenovoRx, Inc. (RNXT) stock is approximately US$59.57M.
The 52-week high for RenovoRx, Inc. (RNXT) stock is US$2.59.
The 52-week low for RenovoRx, Inc. (RNXT) stock is US$0.70.
RenovoRx, Inc. (RNXT) does not currently pay a dividend.
Stay on top of RNXT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
